1. Home
  2. MCY vs MIRM Comparison

MCY vs MIRM Comparison

Compare MCY & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCY
  • MIRM
  • Stock Information
  • Founded
  • MCY 1961
  • MIRM 2018
  • Country
  • MCY United States
  • MIRM United States
  • Employees
  • MCY N/A
  • MIRM N/A
  • Industry
  • MCY Property-Casualty Insurers
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCY Finance
  • MIRM Health Care
  • Exchange
  • MCY Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • MCY 4.3B
  • MIRM 3.8B
  • IPO Year
  • MCY N/A
  • MIRM 2019
  • Fundamental
  • Price
  • MCY $79.93
  • MIRM $68.70
  • Analyst Decision
  • MCY Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • MCY 1
  • MIRM 11
  • Target Price
  • MCY $100.00
  • MIRM $79.00
  • AVG Volume (30 Days)
  • MCY 217.3K
  • MIRM 728.1K
  • Earning Date
  • MCY 11-04-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • MCY 1.59%
  • MIRM N/A
  • EPS Growth
  • MCY 22.11
  • MIRM N/A
  • EPS
  • MCY 7.04
  • MIRM N/A
  • Revenue
  • MCY $5,768,316,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • MCY $7.13
  • MIRM $53.14
  • Revenue Next Year
  • MCY $7.60
  • MIRM $19.83
  • P/E Ratio
  • MCY $11.34
  • MIRM N/A
  • Revenue Growth
  • MCY 14.93
  • MIRM 62.33
  • 52 Week Low
  • MCY $44.19
  • MIRM $36.88
  • 52 Week High
  • MCY $87.67
  • MIRM $78.55
  • Technical
  • Relative Strength Index (RSI)
  • MCY 47.53
  • MIRM 38.20
  • Support Level
  • MCY $76.77
  • MIRM $71.78
  • Resistance Level
  • MCY $80.55
  • MIRM $77.00
  • Average True Range (ATR)
  • MCY 2.39
  • MIRM 2.83
  • MACD
  • MCY -0.81
  • MIRM -0.60
  • Stochastic Oscillator
  • MCY 28.99
  • MIRM 14.80

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: